drugset / Trial / NCT00245609

Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure

NCT00245609

Phase 2 Completed 90 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary purpose of the trial is to assess how effective pregabalin, alprazolam, and placebo are at reducing anxiety levels of subjects who take a dose of these treatments 4 hours before a scheduled dental procedure.

Timeline

Start
2006-01
Primary completion
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Alprazolam Small molecule
Subject Pregabalin Small molecule

Indications

No indication recorded.